There is variation in the literature with regard to dosage regimens. Prednisone mg/kg/day to 1 mg/kg/day PO is commonly reported, followed by gradual taper over 3 to 6 weeks. Use of IV methylprednisolone for a few days may precede oral corticosteroid use. NOTE: Following biopsy to confirm diagnosis, corticosteroids are usually instituted soon afterward as an adjunctive measure; removal of the suspected offending agent /cause is the primary treatment. While many case reports suggest a possible net benefit to the use of corticosteroids, some experts advocate for more prospective study of their value.
Dr. Terek is also an expert in the treatment of patients with osteogenic sarcoma, Ewing sarcoma, chondrosarcoma, soft-tissue sarcoma, metastatic cancer (cancers such as breast, prostate or lung which have spread to the bones), and benign bone and soft tissue tumors. These tumors occur in both children and adults. Treatment usually includes removing the tumor and limb or pelvis reconstruction is performed with combinations of artificial joints and bone grafts. Experts in pediatric, adult, and radiation oncology work with Dr. Terek at Rhode Island Hospital and Hasbro Children’s Hospital as part of a multidisciplinary team to cure patients.
The Cholestatic Liver Disease Consortium (CLiC) is now part of ChiLDREN , the Childhood Liver Disease Research and Education Network. The new and expanded network combines CLiC and the Biliary Atresia Research Consortium (BARC), as well as new studies on cystic fibrosis liver disease. This consolidation seeks to facilitate the discovery of new diagnostics, etiologic, and treatment options for children with rare liver diseases, and those who undergo liver transplantation, and to train the next generation of investigators in rare pediatric liver diseases.